Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, October 21, 2011 - Flublok


Submission Type: BLA    Submission ID: 125285/0    Office: OVRR
Influenza Vaccine
Protein Sciences Corporation
Telecon Date/Time: 21-Oct-2011 01:35 PM        Initiated by FDA? Yes
Telephone Number: E-mail
Communication Categorie(s):
1. Information Request
Telecon Summary:
SRID –b(4)------ data for B strains and process validation 4 (PV4) strains.
FDA Participants: Timothy Fritz
Non-FDA Participants: Penny Post
Trans-BLA Group: No
Related STNs: None
Related PMCs: None
Telecon Body:
From:                    Fritz, Timothy
Sent:                      Friday, October 21, 2011 1:59 PM
To:                         Penny Post (
Subject:                 CBER Information Request for STN 125285 (FluBlok)
Importance:           High
Dear Dr. Post-
Prior to providing advice regarding Protein Sciences Corporation's next fill validation runs, CBER requests that PSC submit the SRID –b(4)----- concentrations determined at time of manufacture for all B/Brisbane/60/2008 monovalent bulk drug substance lots produced to date, and the SRID    -b(4)--- concentrations for lots used in fill validation PV4 (A/California/09 lots ----b(4)-------------------------- A/Perth/09 –b(4)-----; B/Brisbane/08 –b(4)------------------) at the time of fill. Please provide these data as an amendment to STN 125285.
If you have any questions, please contact the Regulatory Project Manager, Dr. Timothy Fritz, at 301-796-2640.
Thank you.
Timothy A. Fritz, Ph.D.
WOC2 HFM-478
1451 Rockville Pike
Rockville, MD 20852
Phone: 301-796-2640
Fax: 301-827-1597
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in error, please notify the sender immediately by e-mail or phone.

Page Last Updated: 02/15/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English